Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck
- Status
- COMPLETED
- Phase
- PHASE1
M6620 First in Human Study
- Status
- COMPLETED
- Phase
- PHASE1
Dose-Dense Induction/Neoadjuvant Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 3 Study of Rilotumumab (AMG 102) With Cisplatin and Capecitabine (CX) as First-line Therapy in Gastric Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Individualized Treatment Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
- Status
- RECRUITING
- Phase
- PHASE2
Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Maximum Tolerated Dose, Safety and Efficacy of Docetaxel / Cisplatin + STI571
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
HOT: HIPEC in Ovarian Cancer as Initial Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas
- Status
- COMPLETED
- Phase
- PHASE1
Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) in Treatment Failure Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE2
Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck
- Status
- COMPLETED
- Phase
- PHASE1